Merit Medical Systems Inc

MMSI

NASDAQ. Currency in USD

70.45 -0.81 ( -1.14% )

Real time prices: December 19

Market Cap.
4.01B
Beta (5Y monthly)
1.02
Price/Earnings
27.97
EPS (TTM)
2.61
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
231,014
1y Target Est.
75.25
Day's Range
70.30
-
71.83
52 Week's Range
50.46
-
76.14

Historical Summary

Performance
EPS growth
Share Buybacks

About Merit Medical Systems Inc

Sector
Healthcare
Industry
Medical Instruments & Supplies
Website
https://www.merit.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
56.46M
Employees
6900
Address
1600 West Merit Parkway, South Jordan, UT, United States, 84095
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Latest news

QuidelOrtho's (QDEL) Latest JV to Boost Footprint in China
QuidelOrtho's (QDEL) Latest JV to Boost Footprint in China

QuidelOrtho's (QDEL) new JV will likely translate into a faster time-to-market and a more compelling...
By Zacks Investment Research - 5 weeks ago

Here's Why Investors Should Retain STERIS (STE) Stock for Now
Here's Why Investors Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS (STE), led by strong segmental growth and the Cantel Medical...
By Zacks Investment Research - 6 weeks ago

Henry Schein (HSIC) Expands Dental Offerings With New Pact
Henry Schein (HSIC) Expands Dental Offerings With New Pact

Henry Schein's (HSIC) latest deal expands its offering in several fast-growing product segments, including clinical...
By Zacks Investment Research - 6 weeks ago

Tandem (TNDM) to Expand Global Insulin Pump Base With New Buy
Tandem (TNDM) to Expand Global Insulin Pump Base With New Buy

The AMF Medical acquisition will help Tandem (TNDM) advance with its sustainability objectives by offering...
By Zacks Investment Research - 6 weeks ago

Here's Why You Should Retain Patterson Companies (PDCO) Stock
Here's Why You Should Retain Patterson Companies (PDCO) Stock

Investors are optimistic about Patterson Companies (PDCO) on the back of its strong product line.
By Zacks Investment Research - 6 weeks ago

Stryker's (SYK) Citrefix to Boost Foot and Ankle Surgeries
Stryker's (SYK) Citrefix to Boost Foot and Ankle Surgeries

Stryker's (SYK) newly-launched Citrefix will help customers avoid chronic inflammation using Citregen. Its pull-out strength...
By Zacks Investment Research - 6 weeks ago

STERIS (STE) Gains on New Orders, FX Impact Dents Growth
STERIS (STE) Gains on New Orders, FX Impact Dents Growth

STERIS (STE) is on track to achieve its stated goal of approximately $50 million of...
By Zacks Investment Research - 6 weeks ago

Medtronic (MDT) Enrolls 1st Patient Trial for Hugo RAS System
Medtronic (MDT) Enrolls 1st Patient Trial for Hugo RAS System

Medtronic's Hugo RAS system is designed to be used in Expand URO U.S. clinical trial...
By Zacks Investment Research - 6 weeks ago